Title

ASCO Coronavirus Resources

As the nation continues to respond to the coronavirus (COVID-19) pandemic, ASCO is committed to providing the most current information and resources to its members and the larger oncology community to help ensure that individuals with cancer receive high-quality care.

ASCO’s COVID-19 Road to Recovery Report

This ASCO report outlines recommendations for the cancer community’s recovery from the pandemic with emphasis on accessible and equitable cancer care and research.
Special Report: A Guide to Cancer Care Delivery During the COVID-19 Pandemic

This ASCO report provides timely guidance on cancer care delivery during the pandemic and testing for COVID-19 in both patients with cancer and in care providers.

ASCO has compiled a wide range of resources to support clinicians, the cancer care delivery team, and patients with cancer. Please continue to check back for the most current information. We are united in working together to continue the critical work of conquering cancer during this health care crisis.

Support COVID-19 Programs Through Conquer Cancer
COVID-19 Patient Care Information
COVID-19 Vaccines & Patients with Cancer
COVID-19 Provider & Practice Information
COVID-19 Government, Reimbursement & Regulatory Updates
ASCO Survey on COVID-19 in Oncology (ASCO) Registry
COVID-19 ASCO/CancerLinQ Insights
COVID-19 Articles from ASCO Journals
Personal Protective Equipment Available Via Project N95

ASCO and Conquer Cancer would like to thank the below donors for generously funding The COVID Impacts Cancer Fund.

Amgen
AstraZeneca
Bayer HealthCare Pharmaceuticals Inc.
BeiGene
Blueprint Medicines
Boehringer Ingelheim Pharmaceuticals, Inc.
Bristol Myers Squibb
Daiichi Sankyo, Inc.
Deciphera Pharmaceuticals, LLC
EMD Serono Inc.
Epizyme
Exelixis, Inc.
GlaxoSmithKline
Genentech BioOncology TM
Gilead Sciences, Inc.
HELSINN
Incyte Corporation
Janssen Pharmaceutical Companies of Johnson & Johnson
Lilly
Melanoma Research Foundation
Merck & Co., Inc.
Natera, Inc.
Nebraska Oncology Society
Novartis Oncology
Novocure
Pfizer Oncology
Sanofi Genzyme
SeaGen Inc.
​TAIHO Oncology, Inc.
Takeda Oncology

FEATURED

Random Quote

"As medical professionals and as a Society, we must all continue to evolve and transform cancer care and research with each new discovery."
Julie M. Vose, MD, MBA, FASCO
ASCO President, 2015-16